Changeflow GovPing Healthcare & Life Sciences DEA Controlled Substance Prescription Rule Corr...
Routine Rule Corrected Corrected

DEA Controlled Substance Prescription Rule Correction

Favicon for www.regulations.gov Regs.gov: Drug Enforcement Administration
Published
Detected
Email

Summary

The Drug Enforcement Administration issued a correction to 21 CFR § 1306.07, fixing paragraph letter references in amendatory instruction 15 from '(e)' and '(f)' to '(g)' and '(h)'. This technical correction to the controlled substance prescribing rule affects entities regulated under DEA's multiple prescription provisions.

Published by DEA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The DEA corrected a typographical error in rule document C1-2026-02288 affecting 21 CFR § 1306.07 (Issuing multiple prescriptions for schedule II controlled substances). The correction changes paragraph references '(e)' and '(f)' to '(g)' and '(h)' in amendatory instruction 15. The underlying rule relates to DEA regulations governing how practitioners may issue multiple prescriptions for Schedule II controlled substances.

This correction does not impose new requirements on regulated entities. No compliance actions, filings, or operational changes are required as a result of this technical correction. Entities already subject to the underlying § 1306.07 requirements should ensure their procedures reflect the corrected paragraph references.

Archived snapshot

Apr 3, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

Correction

In rule document 2026-02288, beginning on page 5216 in the issue of Thursday, February 5, make the following correction:

§ 1306.07 [Corrected] Regulatory Text On page 5242, in the first column, in amendatory instruction 15, paragraphs “(e)” and “(f)” should read “(g)” and “(h)”.

[FR Doc. C1-2026-02288 Filed 3-31-26; 8:45 am] BILLING CODE 0099-10-D

Download File

Download

CFR references

21 CFR 1306.07

Named provisions

§ 1306.07 - Issuing multiple prescriptions for schedule II controlled substances

Get daily alerts for Regs.gov: Drug Enforcement Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DEA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
DEA
Published
March 31st, 2026
Instrument
Rule
Legal weight
Binding
Stage
Corrected
Change scope
Minor
Document ID
FR Doc. C1-2026-02288
Docket
DEA-2020-0029
Supersedes
FR Doc. 2026-02288

Who this affects

Applies to
Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Controlled Substance Scheduling Prescription Writing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Topics
Healthcare

Get alerts for this source

We'll email you when Regs.gov: Drug Enforcement Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!